🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.60
-2.60 (-8.07%)
At close: Nov 20, 2026

BIONET Therapeutics Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
211.96154.4881.325.37-
Revenue Growth
62.95%89.96%1414.60%--
Cost of Revenue
91.9692.8379.33.57-
Gross Profit
120.0161.652.021.8-
Selling, General & Admin
145.18115.8954.146.310.67
Research & Development
60.3962.247.2434.7511.86
Operating Expenses
206.79178.1101.3841.0612.53
Operating Income
-86.78-116.45-99.36-39.26-12.53
Interest Expense
-0.52-0.08---
Interest & Investment Income
16.6418.0311.821.890.02
Other Non Operating Income (Expenses)
1.431.071.290.03-
Pretax Income
-69.24-97.43-86.26-37.34-12.52
Net Income
-69.24-97.43-86.26-37.34-12.52
Net Income to Common
-69.24-97.43-86.26-37.34-12.52
Net Income Growth
-----
Shares Outstanding (Basic)
707057151
Shares Outstanding (Diluted)
707057151
Shares Change
1.91%21.88%280.50%1278.45%-
EPS (Basic)
-0.99-1.39-1.50-2.47-11.43
EPS (Diluted)
-0.99-1.39-1.50-2.47-11.43
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-49.16-138.68-170.95-46.26-3.47
Free Cash Flow Per Share
-0.70-1.98-2.98-3.06-3.17
Gross Margin
56.62%39.91%2.48%33.49%-
Operating Margin
-40.94%-75.38%-122.19%-731.20%-
Profit Margin
-32.67%-63.07%-106.07%-695.44%-
Free Cash Flow Margin
-23.19%-89.77%-210.22%-861.52%-
EBITDA
-63.94-105.43-96.12-38.68-
EBITDA Margin
-30.16%-68.25%-118.21%--
D&A For EBITDA
22.8511.023.240.58-
EBIT
-86.78-116.45-99.36-39.26-12.53
EBIT Margin
-40.94%-75.38%-122.19%--